Oceania Healthcare Limited (OCA.NZ)
NZD 0.74
(1.37%)
NZD 0.74
(1.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 70.2 Million | 105.52 Million | 95.95 Million | 99.36 Million | 89.32 Million | - |
| Net Income | 15.44 Million | 61.12 Million | 102.81 Million | -13.64 Million | 45.37 Million | - |
| Depreciation & Amortization | 17.92 Million | 18.62 Million | 16.24 Million | 14.49 Million | 9.54 Million | - |
| Deferred income taxes | -3.44 Million | -4.87 Million | -10.39 Million | -14.66 Million | -13.57 Million | - |
| Stock-based compensation | 680 Thousand | 678 Thousand | 531.6 Thousand | -172 Thousand | 140 Thousand | - |
| Change in working capital | 16.97 Million | 11.35 Million | 3.8 Million | -2.5 Million | 5.63 Million | - |
| Other non-cash items | 22.63 Million | 18.62 Million | -17.04 Million | 115.86 Million | 42.21 Million | - |
| Investing Cash Flow | -219.6 Million | -218.82 Million | -102.19 Million | -135.98 Million | -153.77 Million | -131.39 Million |
| Investments in PPE | -55.16 Million | -56.28 Million | -36.18 Million | -40.43 Million | -72.89 Million | -33.38 Million |
| Acquisitions | -59.87 Million | -56.2 Million | - | - | 19.69 Million | - |
| Investment purchases | -103.62 Million | -106.31 Million | -66 Million | -95.51 Million | -100.56 Million | -98.17 Million |
| Sales/Maturities of investments | 59.87 Million | 56.2 Million | - | - | -19.69 Million | - |
| Other Investing Activities | -942 Thousand | -6000.00 | -1.00 | -34 Thousand | - | 170 Thousand |
| Financing Cash Flow | 147.08 Million | 43.13 Million | 68.51 Million | 31.47 Million | 68.92 Million | 56.58 Million |
| Debt repayment | -54.29 Million | -115.47 Million | -1.23 Million | -112.62 Million | -84.35 Million | -50.46 Million |
| Dividends payments | -21.8 Million | -19.41 Million | -6.3 Million | -22.22 Million | -28.4 Million | -12.73 Million |
| Common Stock Repurchased | - | 162.51 Million | -91.78 Million | - | 1.29 Million | - |
| Common Stock Issuance | - | 20 Million | 78.06 Million | - | 1.29 Million | - |
| Other Financing Activities | 223.18 Million | -4.48 Million | 89.78 Million | 166.33 Million | 179.09 Million | 119.78 Million |
| Accounts receivables | 5.64 Million | 13.11 Million | -2.27 Million | -2.59 Million | 290 Thousand | - |
| Accounts payables | 11.32 Million | -1.75 Million | 6.07 Million | 90 Thousand | 5.34 Million | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 9.74 Million | 79.9 Million | 17.62 Million | 22.76 Million | 18.28 Million | 10.86 Million |
| Cash at end of period | 7.43 Million | 9.74 Million | 79.9 Million | 17.62 Million | 22.76 Million | 18.28 Million |
| Capital Expenditure | -55.16 Million | -56.28 Million | -36.18 Million | -40.43 Million | -72.89 Million | -33.38 Million |
| Effect of forex changes on cash | - | - | -79.9 Million | - | - | - |
| Net cash flow / Change in cash | -2.3 Million | -70.16 Million | 62.28 Million | -5.13 Million | 4.47 Million | 7.42 Million |
| Free Cash Flow | 15.04 Million | 49.24 Million | 59.76 Million | 58.93 Million | 16.42 Million | -33.38 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 35.15 Million | 17.57 Million | 15.44 Million | 4.25 Million | 2.12 Million | 11.19 Million |
| Depreciation & Amortization | 9.42 Million | 4.71 Million | 17.92 Million | 8.6 Million | 4.14 Million | 9.32 Million |
| Deferred income taxes | - | - | -3.44 Million | -3.44 Million | -3.16 Million | - |
| Stock-based compensation | - | - | 680 Thousand | 340 Thousand | 340 Thousand | - |
| Change in working capital | - | - | 16.97 Million | 2.82 Million | 2.82 Million | - |
| Other non-cash items | 3.44 Million | 1.72 Million | 22.63 Million | 26.24 Million | 13.14 Million | 10.87 Million |
| Investing Cash Flow | -102.61 Million | -51.3 Million | -219.6 Million | -81.22 Million | -40.61 Million | -138.37 Million |
| Investments in PPE | -23.83 Million | -11.91 Million | -55.16 Million | -20.25 Million | 20.05 Million | -35.84 Million |
| Acquisitions | 12.89 Million | - | -59.87 Million | - | - | -59.87 Million |
| Investment purchases | -91.67 Million | - | -103.62 Million | -61.46 Million | - | -42.15 Million |
| Sales/Maturities of investments | 39.39 Million | - | 59.87 Million | - | - | - |
| Other Investing Activities | -39.39 Million | -39.39 Million | -942 Thousand | 500 Thousand | -60.67 Million | -500 Thousand |
| Financing Cash Flow | 57.44 Million | 28.72 Million | 147.08 Million | 44.01 Million | 22 Million | 103.07 Million |
| Debt repayment | -64.2 Million | - | -54.29 Million | -54.55 Million | - | -117.14 Million |
| Dividends payments | -6.76 Million | -3.38 Million | -21.8 Million | -9.26 Million | -4.63 Million | -12.54 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 32.1 Million | 223.18 Million | -1.27 Million | 26.64 Million | -1.53 Million |
| Accounts receivables | - | - | 5.64 Million | 2.82 Million | 2.82 Million | - |
| Accounts payables | - | - | 11.32 Million | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 7.43 Million | - | 9.74 Million | 5.83 Million | 5.83 Million | 9.74 Million |
| Cash at end of period | 10.29 Million | 1.42 Million | 7.43 Million | 7.43 Million | - | 5.83 Million |
| Capital Expenditure | -23.83 Million | -11.91 Million | -55.16 Million | -20.25 Million | 20.05 Million | -35.84 Million |
| Effect of forex changes on cash | - | - | - | - | -6.63 Million | 9.74 Million |
| Net cash flow / Change in cash | 2.85 Million | 1.42 Million | -2.3 Million | 1.6 Million | -5.83 Million | -3.91 Million |
| Free Cash Flow | 24.19 Million | 12.09 Million | 15.04 Million | 18.55 Million | 39.46 Million | -4.45 Million |
GAINZ
CDON
4200
6641
603113
HOM-U